• 1
    MacSween RNM, Burt AD. Histologic spectrum of alcoholic liver disease. Semin Liver Dis 1986; 6: 221232.
  • 2
    Van Waes L, Lieber CS. Early perivenular sclerosis in alcoholic fatty liver: an index of progressive liver injury. Gastroenterology 1977; 73: 646650.
  • 3
    Nakano M, Worner TM, Lieber CS. Perivenular fibrosis in alcoholic liver injury:ultrastructure and histologic progression. Gastroenterology 1982; 83: 777785.
  • 4
    Worner TM, Lieber CS. Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 1985; 254: 627630.
  • 5
    Nasrallah SM, Nassar VH, Galambos JT. Importance of terminal hepatic venule thickening. Arch Pathol Lab Med 1980; 104: 8486.
  • 6
    Parés A, Prats E, Bruguera M, Heredia D, Rodes J. Predictive value of histological features in the progression of alcoholic fatty liver. J Hepatol 1987; 5: 177.
  • 7
    Savolainen ER, Goldberg B, Leo MA, Velez M, Lieber CS. Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease. Alcohol Clin Exp Res 1984; 8: 384389.
  • 8
    Torres M, Parés A, Caballería J, Bruguera M, Jiménez W, Heredia D, Ballesta AM, et al. El péptido aminoterminal del procolágeno tipo III como índice de fibrosis hepática en los alcohólicos crónicos. Gastroenterol Hepatol 1986; 9: 111115.
  • 9
    Heredia D, Caballería J, Parés A, Jiménez W, Torres M, Bruguera M, Rodés J. Serum procollagen type III peptide does not reflect hepatic collagen content in alcoholics with inactive cirrhosis. J Hepatol 1985; 1: S252.
  • 10
    Torres M, Parés A, Caballería J, Jiménez W, Heredia D, Bruguera M, Rodés J. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis. Gastroenterology 1986; 90: 12411246.
  • 11
    Nouchi T, Worner TM, Sato S, Lieber CS. Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver deisease. Alcohol Clin Exp Res 1987; 11: 287291.
  • 12
    Caballería J, Camps J, Giménez A, Parés A, Montull S, Ginés A, Rodés J. Valor de la determinación del péptido aminoterminal del procolágeno tipo III mediante una nueva técnica (Fab RIA) en las hepatopatías alcohólicas. Gastroenterol Hepatol 1989; 12: 6973.
  • 13
    Smedsrid B, Pertoff A, Eriksson B, Eraser RE, Laurent TC. Studies in vitro and on the uptake and degradation of sodium hyaluronate in rat liver endothelial cell. Biochem J 1984; 223: 617626.
  • 14
    McGary CT, Raja RH, Weigel PH. Endocytosis of hyaluronic acid by rat liver endothelian cell: evidence for receptor recycling. Biochem J 1989; 257: 875884.
  • 15
    Engström-Laurent A, Lööf L, Nyberg A, Schröder T. Increased serum levels of hyaluronate in liver disease. Hepatology 1985; 4: 638642.
  • 16
    Bentsen KD, Horn T, Risteli J, Risteli L, Engström-Laurent A, Horslev-Petersen K, Lorenzen I. Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Liver 1987; 7: 339346.
  • 17
    Henriksen JH, Bentsen KD, Laurent TC. Splanchnic and renal extraction of circulating hyaluronan in patients with alcoholic liver disease. J Hepatol 1988; 6: 158166.
  • 18
    Gibson PR, Eraser RE, Brown TJ, Finch CF, Jones PA, Colman JC, Dudley FJ. Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease. Hepatology 1992; 15: 10541059.
  • 19
    Gressner AM, Schafer S. Comparison of sulphated glycosaminoglycan and hyaluronate synthesis and secretion in cultured hepatocytes, fat storing cells and Kupffer cells. J Clin Chem Clin Biochem 1989; 27: 141149.
  • 20
    Guéchot J, Poupon RE, Giral P, Balkau B, Giboideau J, Poupon R. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatol 1994; 20: 388393.
  • 21
    Caballería L, Montull S, Parés A, Deulofeu R, Caballería J, Rodés J. Utilidad de los marcadores biológicos para la detección de alcoholismo y para el diagnóstico de la enfermedad hepática alcohólica. Med Clin (Bare) 1988; 91: 244248.
  • 22
    Centor RM. A Visicalc program for estimating the area under a receiver operating characteristic (ROC) curve. Med Decis Making 1985; 5: 139148.
  • 23
    Ramadori G, Zöhrens G, Manns M, Rider H, Dienes HP, Hess G, Meyer zum Büschenfelde KH. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur J Clin Invest 1991; 21: 323330.
  • 24
    Guechot J, Loria A, Serfaty L, Giral P, Giboudeau J, Poupon R. Serum hyaluronate as a marker of liver fibrosis in chronic viral hepatitis C:effect of α-interferon therapy. J Hepatol 1995; 22: 2226.
  • 25
    Bjermer K, Engtröm-Laurent A, Lindgren R, Rosenhall L, Hällgren R. Hyaluronate and type III procollagen peptide concentrations in bronchoalveolar lavage fluid as markers of disease activity in farmers: lung. BMJ 1987; 295: 803806.
  • 26
    Horslev-Petersen K, Bentsen KD, Engström-Laurent A, Junker P, Halsberg P, Lorenzen I. Serum, aminoterminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis:relation to clinical and serological parameters of inflammation during 8 and 24 months: treatment with levamisole, penicillamine, or azathioprine. Ann Rheum Dis 1988; 47: 116126.
  • 27
    Ericksson S, Fraser JRE, Laurent TC, Pertoft H, Smedsrod B. Endothelial cells are a site of uptake and degradation of hyaluronic acid:a whole body autoradiographic study. Cell Tissue Res 1983; 222: 285293.
  • 28
    Ueno T, Inuzuka S, Torimura T, Tamaki S, Koh H, Kin M, Minetoma T, et al. Serum hyaluronate reflects hepatic sinusoidal capillarization. Gastroenterology 1993; 105: 475481.
  • 29
    Nyberg A, Engström-Laurent A, Lööf L. Serum hyaluronate in primary biliary cirrhosis. A biochemical marker for progressive liver damage. Hepatology 1988; 8: 142146.
  • 30
    Nyberg A, Lundqvist U, Engstrom-Laurent A. Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis:relation to clinical symptoms, liver histopathology and outcome. J Intern Med 1992; 231: 485491.
  • 31
    Sato S, Nouchi T, Worner TM, Lieber CS. Liver fibrosis in alcoholics. Detection by fab radioimmunoassay of serum procollagen III peptides. JAMA 1986; 256: 14711473.
  • 32
    Li J, Rosman AS, Leo MA, Nagai Y, Lieber CS. Tissue inhibitor of metallo-proteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as amarker of fibrosis. Hepatology 1994; 19: 14181423.